DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Consensus Rating of "Hold" by Analysts

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) has earned a consensus recommendation of "Hold" from the twelve brokerages that are currently covering the company, Marketbeat.com reports. Eight investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $27.27.

XRAY has been the subject of a number of recent analyst reports. StockNews.com lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Tuesday, November 19th. Barrington Research decreased their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating for the company in a research report on Friday, November 8th. Evercore ISI reiterated an "in-line" rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday. Morgan Stanley cut their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a report on Tuesday, December 17th. Finally, Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a report on Thursday, November 7th.

DENTSPLY SIRONA Trading Down 3.9 %

DENTSPLY SIRONA stock traded down $0.73 during trading on Friday, reaching $18.12. The company had a trading volume of 2,652,175 shares, compared to its average volume of 2,734,029. DENTSPLY SIRONA has a 12-month low of $17.21 and a 12-month high of $37.35. The stock's 50 day moving average price is $19.27 and its two-hundred day moving average price is $23.15. The firm has a market capitalization of $3.60 billion, a price-to-earnings ratio of -8.75, a PEG ratio of 1.93 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. During the same period in the previous year, the firm earned $0.49 earnings per share. DENTSPLY SIRONA's revenue was up .4% compared to the same quarter last year. As a group, equities analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Shareholders of record on Friday, December 27th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.53%. The ex-dividend date of this dividend is Friday, December 27th. DENTSPLY SIRONA's dividend payout ratio is presently -30.92%.

Institutional Trading of DENTSPLY SIRONA

A number of hedge funds have recently bought and sold shares of XRAY. JPMorgan Chase & Co. lifted its position in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after purchasing an additional 1,244,326 shares in the last quarter. Scientech Research LLC purchased a new stake in shares of DENTSPLY SIRONA in the second quarter worth approximately $846,000. Barclays PLC lifted its position in shares of DENTSPLY SIRONA by 21.8% in the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock worth $8,301,000 after purchasing an additional 54,920 shares in the last quarter. Quantinno Capital Management LP lifted its position in shares of DENTSPLY SIRONA by 276.5% in the third quarter. Quantinno Capital Management LP now owns 116,808 shares of the medical instruments supplier's stock worth $3,161,000 after purchasing an additional 85,787 shares in the last quarter. Finally, VELA Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA in the third quarter worth approximately $2,168,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.